In situ hybridization technology, as a core tool in molecular biology and medical research, provides key data for disease diagnosis, gene function analysis, and developmental biology research by detecting the localization and expression of specific nucleic acid sequences in tissues or cells. However, the traditional manual operation mode has pain points such as low experimental efficiency, poor repeatability, and high risk of human error. With the integration of optical microscopy technology, microfluidics technology, embedded control, and AI algorithms, in situ hybridization instruments are undergoing a leapfrog development from manual operation to semi automation to full process AI assisted intelligent platforms, driving experimental accuracy, flux, and repeatability into a new stage.
1、 Limitations of traditional manual operation: dual challenges of efficiency and accuracy
The process is cumbersome, time-consuming, and labor-intensive
Traditional in situ hybridization requires manual completion of more than ten steps, including sample fixation, permeabilization, pre hybridization, hybridization, washing, and detection. A single experiment takes 12-24 hours and requires researchers to be on duty throughout the entire process, resulting in high operational intensity.
Human error affects the repeatability of results
The problems of manual sample addition, temperature control (such as missing fuzzy PID algorithm resulting in temperature difference>± 2 ℃), and inconsistent washing time have caused significant fluctuations in the experimental results. Research has shown that under manual operation, the difference in fluorescence signal intensity between different batches of experiments can reach more than 30%, which seriously restricts the standardized application of clinical diagnosis.
Efficiency bottleneck in high-throughput scenarios
In drug screening or large-scale gene expression analysis, manual operation is difficult to meet the demand of processing tens to hundreds of samples simultaneously, which limits the research scale and speed.
2、 Breakthrough in Automation Technology: From "Mechanical Substitution" to "Intelligent Optimization"
Core module automation: precise temperature control and humidity locking
Fuzzy PID temperature control algorithm: By real-time feedback adjustment of heating power, temperature fluctuation of ≤± 0.5 ℃ is achieved (such as the Venide HB-500 model), ensuring the specificity of hybridization reaction.
Fully sealed humidity control system: using humidity sensors in conjunction with humidification modules to maintain a hybridization environment humidity of ≥ 90% RH and prevent sample evaporation.
Automated slide slot design: supports the "open cover operation" mode, reduces manual contact, and lowers the risk of contamination.
Process integration: from "step-by-step operation" to "one click operation"
Transgender hybridization integrated process: Controlled by an embedded system, it automatically completes DNA double strand melting (95 ℃, 5-10 minutes) and hybridization reaction (42 ℃, 12-16 hours), reducing experimental time by more than 50%.
Gradient washing automation: Built in multi concentration washing solution (2 × SSC, 1 × SSC, etc.) pumping system, precise control of washing temperature (37 ℃) and time (10-15 minutes/time), reducing background signal interference.
Intelligent Interconnection and Data Traceability
Real time temperature curve visualization: Monitor the experimental progress through a 7-inch touch screen or mobile app, and support data export and storage.
AI assisted result analysis: Combined with deep learning algorithms, automatically identify fluorescence signal intensity and distribution patterns, and quantify target gene expression levels.
3、 AI assisted intelligent platform: ushering in the era of unmanned experiments for in situ hybridization
Adaptive experimental parameter optimization
AI automatically recommends optimal parameter combinations by analyzing historical experimental data, such as the correlation between temperature, humidity, hybridization time, and signal strength.
Anomaly detection and real-time error correction
The machine vision system monitors the status of glass slides in real time (such as sample drying and probe aggregation), identifies anomalies through AI algorithms, and triggers alarms or automatically adjusts parameters.
Full process automation and robot collaboration
Combining robotic arm and microfluidic technology to achieve full chain automation from sample loading, hybridization reaction to result analysis.
4、 Application scenario expansion: from basic research to clinical diagnosis
Accurate diagnosis of tumors
The automated platform can quickly detect the EGFR mutation of lung cancer, HER2 amplification of breast cancer and other markers, providing molecular basis for targeted therapy. Research has shown that AI assisted FISH testing reduces diagnostic time from 48 hours to 8 hours, with a 99.2% consistency with the gold standard.
Pathogen detection and public health
In the diagnosis of COVID-19, HPV and other virus infections, the high-throughput automation platform can realize rapid screening of thousands of samples every day.
Developmental Biology and Neuroscience Research
Combined with live imaging technology, the AI assisted platform can monitor the dynamic changes in gene expression in zebrafish embryos in real time, revealing neural mechanisms such as olfactory perception and reproductive behavior.
5、 Future outlook: Technology integration drives industry transformation
Microfluidic chips and single-cell resolution
Microfluidic technology can achieve in situ hybridization at the single-cell level, combined with AI algorithms to analyze cell heterogeneity, promoting research on tumor microenvironment, immune cell interactions, and more.
Multimodal data fusion
Integrating in situ hybridization, spatial transcriptomics, and in vivo imaging data to construct a cross scale model of gene expression protein function cell behavior, providing a panoramic analysis of disease mechanisms.
Cloud based experiment management and remote collaboration
Through 5G+AI technology, real-time uploading and global sharing of experimental data are achieved, supporting cross laboratory collaboration and standardized quality control, accelerating the transformation of scientific research achievements.
Conclusion
The automation and intelligent transformation of in situ hybridization machines is not only an upgrade in technology, but also a transformation in the paradigm of life science research. From "craftsmen" to "AI scientists", this process is reshaping experimental efficiency, data quality, and research boundaries. In the future, with the continuous optimization of AI algorithms and the deepening of multi technology integration, in situ hybridization technology will move towards a new stage of higher throughput, higher accuracy, and intelligence, providing stronger tools for human health and life science exploration.